Trial
NCT03175978
IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
IGF Oncology, LLC
Collaborators
—
Condition
Myelodysplastic Syndromes
Intervention
IGF/MTX
Why stopped
Funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-21